<html>
<head>
<title>Section 327:6-b Joint Pharmaceutical Formulary and Credentialing Committee.</title>
<!-- Hide metadata
<titlename>TITLE XXX OCCUPATIONS AND PROFESSIONS</titlename>
<chapter>CHAPTER 327 OPTOMETRY</chapter>
<sectiontitle>Section 327:6-b Joint Pharmaceutical Formulary and Credentialing Committee.</sectiontitle>
-->
</head>
<body>
<center><h1>TITLE XXX<br>OCCUPATIONS AND PROFESSIONS</h1></center>
<center><h2>CHAPTER 327<br>OPTOMETRY</h2></center>
<center><h2>Examinations and Licenses</h2></center>
<center><h3>Section 327:6-b</h3></center>
&nbsp;&nbsp;&nbsp;<b> 327:6-b Joint Pharmaceutical Formulary and Credentialing Committee. &#150;</b>
<codesect>
<br>
&nbsp&nbsp&nbsp
I. The joint pharmaceutical formulary and credentialing committee shall be comprised of 3 optometrists licensed under RSA 327 appointed by the New Hampshire Optometric Association, 3 ophthalmologists licensed under RSA 329 appointed by the New Hampshire Society of Eye Physicians and Surgeons, and 3 pharmacists licensed under RSA 318 appointed by the pharmacy board.  Members shall serve terms of 5 years and shall not be eligible for a second consecutive term.  The initial members shall be appointed for staggered terms as follows:  one optometrist, one ophthalmologist, and one pharmacist for a term of 5 years;  one optometrist, one ophthalmologist, and one pharmacist for a term of 4 years;  and one optometrist, one ophthalmologist, and one pharmacist for a term of 3 years.  All members shall be residents of the state of New Hampshire.  Neither they nor their spouses shall have any material financial interest in the provision of eye care services other than that which is directly related to the practice of their professions.  Matters to be brought before the committee shall be filed in writing with the chairperson at least 30 days prior to the scheduled meeting.  Any member of the committee may submit items to be assigned to the agenda for consideration.  Agendas shall be posted on the board of optometry's public access Internet site at least 10 days prior to committee meetings.
<br>
&nbsp&nbsp&nbsp
II. The committee shall meet quarterly to:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) Review and develop glaucoma reporting forms;
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) Develop a glaucoma credentialing form and patient consent form;
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) Review suggestions, complaints, and concerns regarding the glaucoma certification process described in RSA 327:6-c, II, and report the results of its review to the board.  This subparagraph shall not grant the committee additional authority or powers not stated in this subparagraph;
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(d) Provide minutes of their meetings to the board, the board of medicine, and the pharmacy board;  and
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(e) Determine which optometrists have successfully completed the requirements of RSA 327:6-c and maintain a list of such optometrists.
<br>
&nbsp&nbsp&nbsp
III. [Repealed.]
</codesect>
<sourcenote>
<p><b>Source.</b>  1985, 245:2.  1993, 333:10.  2002, 274:2.  2006, 182:3, 6, eff. July 24, 2006.</p>
</sourcenote>
</body>
</html>
